- Home
- RDI vs DARE Comparison
RDI vs DARE Comparison
Compare RDI & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDI
- DARE
- Stock Information
- Founded
- RDI 1937
- DARE 2015
- Country
- RDI United States
- DARE United States
- Employees
- RDI N/A
- DARE N/A
- Industry
- RDI Movies/Entertainment
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- RDI Consumer Discretionary
- DARE Health Care
- Exchange
- RDI Nasdaq
- DARE Nasdaq
- Market Cap
- RDI 27.9M
- DARE 26.3M
- IPO Year
- RDI N/A
- DARE N/A
- Fundamental
- Price
- RDI $1.34
- DARE $2.83
- Analyst Decision
- RDI Hold
- DARE Strong Buy
- Analyst Count
- RDI 1
- DARE 3
- Target Price
- RDI $2.40
- DARE $12.50
- AVG Volume (30 Days)
- RDI 30.0K
- DARE 4.3M
- Earning Date
- RDI 08-13-2025
- DARE 08-11-2025
- Dividend Yield
- RDI N/A
- DARE N/A
- EPS Growth
- RDI N/A
- DARE N/A
- EPS
- RDI N/A
- DARE N/A
- Revenue
- RDI $205,644,000.00
- DARE $25,909.00
- Revenue This Year
- RDI $7.47
- DARE $99,756.91
- Revenue Next Year
- RDI $13.22
- DARE $119.77
- P/E Ratio
- RDI N/A
- DARE N/A
- Revenue Growth
- RDI N/A
- DARE N/A
- 52 Week Low
- RDI $1.17
- DARE $2.11
- 52 Week High
- RDI $1.89
- DARE $9.19
- Technical
- Relative Strength Index (RSI)
- RDI 48.07
- DARE 64.97
- Support Level
- RDI $1.24
- DARE $2.11
- Resistance Level
- RDI $1.34
- DARE $9.19
- Average True Range (ATR)
- RDI 0.06
- DARE 0.57
- MACD
- RDI 0.00
- DARE 0.07
- Stochastic Oscillator
- RDI 52.63
- DARE 13.49
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.